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Mucopolysacchariduria is a feature of mucopolysaccharide (MPS) storage diseases: Hurlers (MPSI), Hunter's (MPSII), and Sanuilippo's (MPSffl) syndromes. The first step in differential diagnosis is identification of MPS by electrophoresis on cellulose acetate membranes (1). Before electrophoresis, MPS is concentrated by precipitation with quaternary salts such as cetylpyridinium chloride or a dye such as Alcian blue (1). These tedious and time-consuming methods require periods of standing, extensive washing, and centrifugation. Low-molecular-mass species may not be isolated by these prOcedUres.
We describe a procedure for simple, rapid ultrafiltration in a 10-mL stirred "Omegacell" (Pharmacia LKB Biotechnology Inc., Piscataway, NJ) to concentrate urine for MPS electrophoresis.
After preliminary screening (2), 3 mL of each MPS-positive specimen is placed in an Omegacell and ultrafiltered through a membrane with a 10 000-Da cutoff. The cell is connected to an air line to exert a pressure of approximately 2.7 kg/cm2. With magnetic stirring, 3 mL of urine can be concentrated to 0.3 mL in 10 to 15 mm. Filtrate and retentate can be retested for presence of MPS (2). For most specimens, MPS was retained by the membrane; in a few, MPS was found in both filtrate and retentate.
When the process was repeated with use of a 3000-Da cutoff membrane, about 45 mm was required to reduce the volume of the specimen to 0.1 of the original.
Electrophoresis was carried out in a 0.1 mol/L barium acetate buffersystem (pH 6.0) with constant current, 5 mA per 15 x 2.5 cm strip. After staining the strips in Alcian blue (1) and destaining in water, we transferred them to glyceroliwater (1/9 by vol) and soaked them for 1 h. This removes residual dye and prevents breaking of the strips.
The electrophoretic pattern was identical regardless of molecular size. In a patient with MPS I, dermatan sulfate retained by the 10-kDa-cutoff membrane migrated with the dermatan sulfate that was filtered through the 10-kDacutoff membrane but retained by the 3-kDa-cutoff membrane. The procedure may be useful in monitoring patients for MPS of decreased molecular size after bone-marrow transplant.
The stirred cell can be re-used if it is cleaned and stored in glycerollwater (1/19 by vol) at 4 #{176}C. Distilled water (5 niL) should be ifitered through the membrane before re-use.
Direct Determination of Arginine-Vasopressin
In Urine,
is measured, either in plasma or in urine, for differential diagnosis of chronic hyponatremia, diabetes insipidus, ectopic AVP production, and psychogenic water intoxication.
Different RIA techniques have been applied to assay of AVP in extracts of plasma and urine (1, 2). However, the extraction procedures are complex and recoveries are poor and variable.
Furthermore, the extraction procedurereportedly essential for determination of low AVP concentrations in plasma-is not necessarily a prerequisite for assay of urine.
Our aim here was to develop a simple, rapid assay for urinary AVP without extraction and to compare it with methods in current use.
Twenty-four-hour specimens of human urine were collected in the presence of 10 mL of 6 moIJL HC1 as preservative; aliquots were diluted two-and fourfold with the RJA buffer from a commercially available RIA kit (BUhlmann Laboratories AG, Basel, Switzerland), the pH of which was adjusted to 7.5 with drops of 2 molIL NaOH and directly assayed with the kit. We extracted AVP from another urine aliquot by the modified method of Mehra To measure the inimunoreactive AVP with or without extraction, we modified the RIA kit by using a longer incubation after the second antibody addition (60 mm vs 30 mm) and washing the precipitate with 1 mL of de-ionized water to decrease nonspecific binding.
Intra-assay CVs for direct analysis of control urines (n = 27, mean = 51.2 pg/mL) were 7.7% and 6.7% for samples diluted two-and fourfold, respectively.
Serial twofold dilutions of 10 urine samples showed a good linear response to dilution. Moreover, the curves for the dilutions of the urine specimens paralleled the standard curve, confirming the immunological identity of measured product and synthetic AVP (Figure 1) . These dried metabolites were reconstituted in 20 L of methanol and either 500 L of human drug-free serum or EDTA-treated whole blood and further diluted with their respective matrix to give six different concentrations, auquots ofwhich were assayed in two different runs with both ELks, in serum and whole blood, according to the respective kit protocols. The concentrations of metabolites used presented a suppression line ranging from 90% to 10% B/B0. All metabolites were examined in the same run to eliniinate error due to run-to-run variability. In addition, to check the validity of each run, we included a reference set of Sandoz CsA calibrators in each run of CYCLO-Trac SP. Table 1 lists percentage cross-reactivities of metabolites. Results are expressed as the ratio (CsA concentrationlmetabolite concentration) x 100 at 50% inhibition of maximum binding. Analyses ofthe suppression lines confirmed that all metabolite lines paralleled the CsA line. The cross-reactivities never exceeded 3% in either method. Among the metabolites tested, metabolite 1 showed the greatest (2.5%), whereas metabolite 8 showed the least (<0.1%). In serum, the cross-reactivity appears greater in CYCLO-Trac SP than in Sandimmune. However, all cross-reactivities are so low as to be of doubtful clinical significance. This study was supported by INCSTAR Corp.
